Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1993-09-21
1998-12-01
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
4241851, 514 2, 514 8, 514 21, 514825, A61K 3900, A61K 3702, A61K 3712
Patent
active
058434453
ABSTRACT:
The present invention is directed to a method and pharmaceutical formulations for the treatment of autoimmune arthritis and animal models therefore in mammals, including humans, by the oral, enteral or by-inhalation administration of whole collagen protein or biologically active peptide fragments of collagen.
REFERENCES:
Zamvil et al., Nature, 324:258-260, 1986.
Fritz et al., J. Immunol., 134:2328-2332, 1985.
Fritz et al., J. Immunol. 130:191-194, 1983.
Pettinelli et al., J. Immunol., 129:1209-1211, 1982.
Whitaker et al., J. Bio. Chem, 250:9106-9111, 1975.
Friedman et al., PNAS, 91:6688-6692, 1994.
Bitar, dissertation entitled, The Suppressive Effects of Oral Myelin Basic Protein . . . , 1986.
Nagler-Anderson, dissertation entitled, Immunoregulation of an Exp. Model of Autoimmunity, 1986.
Rothbart, 1st Forum in Virology, pp. 518-520, 1986.
Eylar et al., Neurochem. Research, 4:249-258, 1979.
Kagnoff, Oral Tolerance, pp. 248-269, 1982.
Carnegie et al.,Immunol. 19:55-63, 1970.
Fritz et al., J. Immunol., 130:1024-1026, 1983.
Hashim et al., Arch. Biochem. and Biophy., 156:287-297, 1973.
P.J. Higgins and H.L. Weiner, J. Immunol. 140:440 (1988).
D. Bitar and C.C. Whitacre, Cell. Immunol. 112:364 (1988).
C.C. Whitacre, I.E. Gienapp, C.G. Orosz, D. Bitar, J. Immunol. 147:2155 (1991).
R.B. Nussenblatt et al., J. Immunol. 144:1689 (1990).
O. Lider, L.M.B. Santos, C.S.Y. Lee, P.J. Higgins, H.L. Weiner, J. Immunol. 142:748 (1989).
L.M.B. Santos, A. Al-Sabbagh, A. London, H.L. Weiner, J. Immunol. 150:115A (1993) (abstract).
A. Miller, O. Lider, H.L. Weiner, J. Exp. Med. 174:791 (1991).
S.J. Khoury, W.W. Hancock, H.L. Weiner, J. Exp. Med. 176:1355 (1992).
A. Miller, O. Lider, A. Roberts, M.B. Sporn, H.L. Weiner, Proc. Natl. Acad. Sci. USA 89:421 (1992).
Z.J. Zhang, L. Davidson, G. Eisenbarth, H.L. Weiner, Proc. Natl. Acad. Sci. USA 88:10252 (1991).
H.L. Weiner et al., Science 259:1321 (1993).
C. Nagler-Anderson, L.A. Bober, M.E. Robinson, G.W. Siskind, G.J. Thorbecke, Proc. Natl. Acad. Sci. USA 83:7443 (1986).
H.S.G. Thompson and N.A. Staines, Clin. Exp. Immunol. 64:581 (1985).
Z.J. Zhang, C.S.Y. Lee, O.Lider, H.L. Weiner, J. Immunol. 145:2489 (1990).
R.S. Pinals, A.T. Masi, R.A. Larsen, Arthritis Rheum. 24:1308 (1981).
O.Steinbrocker, C.H. Traeger, R.C. Batterman, JAMA 140:659 (1949).
H.J. Williams et al., Arthritis Rheum. 31:702 (1988).
M.E. Weinblatt et al., N.Eng. J. Med. 312:818 (1985).
Holoshitz, J. et al, J. Immunol. 131:2810, 1983.
Holoshitz, J. et al, Science 219:56, 1983.
Kardys, E. et al., J. Immunol. 127:862, 1981.
Lando, Z. et al., Nature 287:551, 1980.
Lando, Z. et al., J. Immunol. 126:1526, 1981.
Lane, I. William et al., Sharks Don't Get Cancer, Avery Publishing Group Inc., 1992, updated edition 1993.
Lider, O. et al., J. Immunol. 142:748, 1989.
McDermott, J. R. et al., J. Neuro. Sci. 46:137, 1980.
McKenna, R. M. et al, Cell. Immun. 81:391, 1983.
McKenna, R. M. et al., Cell Immun. 88:251, 1984.
Mokhtarian, F. et al.,Nature 309:356, 1984.
Mowat, A. M., Immunol. Today 8:93, 1987.
Myers, L. K. et al., J. Exp. Med. 170:1999, 1989.
Myers, L. K. et al., J. Immunol. 143:3976, 1989.
Newman, S.P. in Aerosols and the Lung, Clarke, S.W. and Davia, D., eds. pp. 197-224, Butterworths, London, England, 1984.
Ngan, J. et al., J. Immunol. 120:861, 1978.
Phadke, et al., Arthritis and Rheumatism 27:797, 1984.
Raine, C. S. et al., Lab. Invest. 48:275, 1983.
Rama, et al., Connective Tissue Research 12:111, 1984.
Raziuddin, S. et al., J. Immunol. 128:2073, 1982.
Schoen, R. T. et al., J. Immunol. 128:717, 1982.
Sewel, K.L. and Trentham, D.E., The Lancet 341:283, 1993.
Sriram, S. et al., Cell. Immunol. 75:378, 1983.
Strejan, G. H. et al., Cell Immun. 84:171, 1984.
Swierkosz, J.E. et al., J. Immunol. 119:1501, 1977.
Titus, R.G. et al., Int. Arch. Allergy Appl. Immunol. 65:323, 1981.
Traugott, U. et al., J. Neurol. Sci. 56:65, 1982.
Trentham, D. E. et al., J. Clin. Invest. 66:1109, 1980.
Trentham, D. E. et al., Science 261:1727, 1993.
Weinblatt, M.E. et al., N. Eng. J. Med. 312:818, 1985.
Wells, H., J. Infect. Dis. 9:147, 1911.
Whitacre, C. C. et al., Titles of Workshop Presentations, No. 615-09, 5th Int'l. Congr. of Immunol., Kyoto, Japan, 1983.
Whitacre, C. C. et al., 6th Int'l. Cong. Immunol., Toronto, Jul. 1986, Abstract 3.62.21, Dist. to Reg. Attendees Upon Request, May 1986.
Zhang, Z.J., et al., FASEB J. 4(7):Abstract 3264, 1990.
AutoImmune Press Release of May 12, 1997.
Trentham David E.
Weiner Howard L.
Achutamurthy Ponnathapura
AutoImmune Inc.
LandOfFree
Method of treating rheumatoid arthritis with type II collagen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating rheumatoid arthritis with type II collagen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating rheumatoid arthritis with type II collagen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2393450